October 15, 2025 · Form 4 insider transaction
Kelly Thomas Patrick bought 225,000 shares of XENON PHARMACEUTICALS INC at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Vesting 25% on October 15, 2026, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.